Profile of The Use Of Biquanide And Sulfonylurea Combination Drugs In Patients With Type 2 Diabetes Mellitus

Authors

  • Nafisah Isnawati Universitas dr. Soebandi Author
  • Nafisah Isnawati Author

Keywords:

biguanide, sulfonylurea, profile

Abstract

Diabetes  mellitus (DM) was disease caused by a disorder of the pancreas where the insulin produced cannot be used properly by the body. This study aimed to determine the profile of the use of a combination of biguanid and sulvonylurea in patinet with type 2 diabets mellitus. this research was non experimental research with retrospective data colleteion methode and descriptive reasearhc design. the data source used is the patient's medical record  data. the sample in this study was all type 2 diabetes mellitus patinet whoused combination biguanide and sukfonylurea drug at X jember hospital from October to November 2023 with a total of 50 patients. The sampling technique   used the total sampling technique. The result showed that nearly half of the patient with type 2 diabetes mellitus were in the age range of 51-60 years by 20 (40%) and most of the patient were female, 32 (64%). the use of combination of biguanide an dsulfonylurea drugs, almost all patinet used a combination of metformin and glimepirid as many as 65(94,2%), for almost half the dose used metformin 500 mg and glimepirid  4 mg as many as 25 (36,2%) while the frequency of a small proportionused metformin 500 mg twice a day and glimepirid 4 mg once a day. type 2 diabetes mellitus patiens mostly suffer from the age range of 51-60 years and most of the patinet are female. The use of a combination of biquanid and sulfonyl urea drugs, most of the drugs used are metformin 500 mg twice a dat and glimepirid 4 mg once a day 

References

Artini, K. S., Saifana, C. S., & Federation, I. D. 2022. Gambaran Penggunaan Antidiabetes Oral Pada Pasien Diabetes Mellitus Tipe 2 : Literature Review. SIKesNas, 2045, 333–340.

Febrinasari, R. P., Sholikah, T. A., Pakha, D. N., & Putra, S. E. 2020. Buku Saku Diabetes untuk Awam. November, 1–78. Surakarta.

Furdiyanti, N. H., Luhurningyyas, F. P., & Yulianti, R. S. 2017. Evaluasi Dosis Dan Interaksi Obat Antidiabetika Oral Pada Pasien Diabetes Mellitus Tipe Ii. Jurnal Manajemen Dan Pelayanan Farmasi, 7(4): 191–196.

Gunawan, S., & Rahmawati, R. 2021. Hubungan Usia, Jenis Kelamin dan Hipertensi dengan Kejadian Diabetes Mellitus Tipe 2 di Puskesmas Tugu Kecamatan Cimanggis Kota Depok Tahun 2019. ARKESMAS (Arsip Kesehatan Masyarakat), 6(1): 15–22. https://doi.org/10.22236/arkesmas.v6i1.5829

Kuna, Mega, Manika, P. 2022. Analisis Penggunaan Obat Pada Pasien Diabetes Melitus Di Puskesmas Goagoman Tahun 2022. Jurnal Cakrawala Ilmiah, 2(4): 1–23.

Lestari, Zulkarnain, & Sijid, S. A. 2021. Diabetes Melitus: Review Etiologi, Patofisiologi, Gejala, Penyebab, Cara Pemeriksaan, Cara Pengobatan dan Cara Pencegahan. UIN Alauddin Makassar, November, 237–241. http://journal.uin-alauddin.ac.id/index.php/psb

PERKENI. 2021. Pedoman Petunjuk Praktis Terapi Insulin Pada Pasien Diabetes Mellitus 2021. Jakarta. Pb Perkeni, 32–39.

Putri, N. A. 2019. Efek Penambahan Zink pada Terapi Glimepirid Terhadap Kadar Glukosa Darah Mencit yang di Induksi Streptozotocin. In Digital Digital Repository Repository Universitas Universitas Jember.

Rasdianah, N., & Pakaya, M. 2023. Studi Interaksi Obat Pasien Diabetes Melitus Tipe 2 dengan penyakit penyerta : Studi Kasus Rumah Sakit X Gorontalo. Journal SY, 5, 192–199.

Soelistijo, S. 2021. Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia 2021. Jakarta. Global Initiative for Asthma, 46. www.ginasthma.org.

Timur, W. W., Rizkiani, A. A., & Widyaningrum, N. 2022. Perbandingan Efektivitas Metformin-Glimepirid Versus Metformin-Vildagliptin Terhadap Kadar Gula Darah Pasien DM Tipe 2 Di Rumah Sakit Islam Sultan Agung Semarang 2022. Cendekia Journal of Pharmacy, 6(2): 291–300.

Vadila, A., Izhar, M. D., & Nasution, H. S. 2021. Faktor-Faktor Kejadian Diabetes Melitus Tipe 2 Di Puskesmas Putri Ayu. XVI(2): 229–237.

Widodo, W. 2017. Monitoring of Patient With Diabetes Mellitus. Jurnal Ilmiah Kedokteran Wijaya Kusuma, 3(2): 55. https://doi.org/10.30742/jikw.v3i2.23

Wulandari, A., & Melati, R. S. 2021. Kesesuaian penggunaan obat antidiabetes pada pasien diabetes melitus di puskesmas x Palembang. Borneo Journal of Pharmascientech,05(02).http://www.jurnalstikesborneolestari.ac.id/index.php/borneo/article/view/388%0Ahttp://www.jurnalstikesborneolestari.ac.id/index.php/borneo/article/download/388/258

Downloads

Published

2024-06-05

How to Cite

Profile of The Use Of Biquanide And Sulfonylurea Combination Drugs In Patients With Type 2 Diabetes Mellitus. (2024). The Health Researcher’s Journal, 1(02), 1-5. https://journal.forumsdgs.or.id/index.php/hrj/article/view/9